LRP2/Megalin Is Required for Patterning of the Ventral Telencephalon Robert Spoelgen*, Annette Hammes*, Uwe Anzenberger*, Dietmar Zechner, Olav M

Total Page:16

File Type:pdf, Size:1020Kb

LRP2/Megalin Is Required for Patterning of the Ventral Telencephalon Robert Spoelgen*, Annette Hammes*, Uwe Anzenberger*, Dietmar Zechner, Olav M Research article Development and disease 405 LRP2/megalin is required for patterning of the ventral telencephalon Robert Spoelgen*, Annette Hammes*, Uwe Anzenberger*, Dietmar Zechner, Olav M. Andersen, Boris Jerchow and Thomas E. Willnow† Max-Delbrueck-Center for Molecular Medicine, Berlin, 13092, Germany *Authors contributed equally †Author for correspondence (e-mail: [email protected]) Accepted 10 November 2004 Development 132, 405-414 Published by The Company of Biologists 2005 doi:10.1242/dev.01580 Summary Megalin is a low-density lipoprotein receptor-related ventral forebrain. As a consequence of absent SHH activity, protein (LRP2) expressed in the neuroepithelium and the ventrally derived oligodendroglial and interneuronal cell yolk sac of the early embryo. Absence of megalin expression populations are lost in the forebrain of megalin–/– embryos. in knockout mice results in holoprosencephaly, indicating Similar defects are seen in models with enhanced signaling an essential yet unidentified function in forebrain through BMPs, central regulators of neural tube development. We used mice with complete or conditional patterning. Because megalin mediates endocytic uptake megalin gene inactivation in the embryo to demonstrate and degradation of BMP4, these findings indicate a role for that expression of megalin in the neuroepithelium but not megalin in neural tube specification, possibly by acting as in the yolk sac is crucial for brain development. During BMP4 clearance receptor in the neuroepithelium. early forebrain development, megalin deficiency leads to an increase in bone morphogenic protein (Bmp) 4 expression Key words: LDL receptor-related proteins, Bone morphogenic and signaling in the rostral dorsal neuroepithelium, and a proteins, Sonic hedgehog, Yolk sac, Holoprosencephaly, Mouse, subsequent loss of sonic hedgehog (Shh) expression in the LRP2 Introduction axis into discrete hemispheres. This defect is likely to be the Development Low-density lipoprotein (LDL) receptor-related proteins result of defective patterning during development involving (LRPs) are multifunctional cell surface receptors structurally improper specification of the rostral portion of the neural tube. related to the LDL receptor (Nykjaer and Willnow, 2002). Many genetic pathways involved in neural tube patterning have been implicated in the etiology of HPE (Wallis and Muenke, Initially considered endocytic receptors involved in lipoprotein 1999). In particular, alterations in pathways that specify the metabolism, recent studies revealed important roles for LRPs dorsoventral axis of the rostral neural tube may cause this in the regulation of many signaling processes (Nykjaer and syndrome. For example, increased dorsal signaling through Willnow, 2002; Herz and Bock, 2002). For example, LRP5 and bone morphogenic proteins (BMPs), members of the LRP6 bind WNT proteins and WNT inhibitors, and act as co- transforming growth factor β superfamily, and through WNT receptors for Frizzled in determining pattern formation in the proteins, results in HPE (Golden et al., 1999; Wallis et al., early embryo (Pinson et al., 2000; Wehrli et al., 2000; Mao et 1999; Anderson et al., 2002; Lagutin et al., 2003). Also, loss al., 2001a; Mao et al., 2001b), while apolipoprotein E receptor- of sonic hedgehog (SHH) expression, a factor that specifies the 2 and very low-density lipoprotein receptor function as ventral neural tube, leads to holoprosencephalic syndrome in receptors for Reelin, a signaling factor that controls neuronal humans and in mice (Chiang et al., 1996; Roessler et al., 1996). migration in the embryonic brain (Trommsdorf et al., 1999; Concerning a role for megalin in forebrain development, Hiesberger et al., 1999; D’Arcangelo et al., 1999). some evidence suggests involvement of the receptor in the LRP2, or megalin (herein referred to as megalin), is another SHH pathway (McCarthy et al., 2002; Farese and Herz, 1998). member of the LDL receptor gene family essential for brain Sonic hedgehog is a secreted protein expressed in the development (Saito et al., 1994; Willnow et al., 1996). At mid- notochord and the floorplate that undergoes autocatalytic gestation, the receptor is expressed in the neuroepithelium of the cleavage into a 19 kDa amino terminal (SHH-N) and a 25 kDa embryo as well as in the visceral endoderm of the yolk sac carboxyl terminal (SHH-C) domain. During cleavage, a (Willnow et al., 1996; Zheng et al., 1994). Targeted disruption cholesterol moiety becomes covalently attached to SHH-N, the of the respective gene in the mouse results in holoprosencephalic active fragment that binds to the receptor Patched (Ptch1) and syndrome and in perinatal lethality (Willnow et al., 1996). activates downstream SHH target genes through Smoothened However, the exact mechanism by which megalin contributes to (Smo). Cholesterol modification of SHH-N is crucial for forebrain formation, and why holoprosencephaly (HPE) ensues proper activity, perhaps by spatially restricting SHH activity in megalin-deficient mice, is still unclear. (Porter et al., 1996). Expression of megalin in the yolk sac and Holoprosencephaly is defined as a failure of the its ability to take up lipoproteins suggests a possible function prosencephalon (forebrain) to separate along the mid-sagittal for the receptor in delivery of cholesterol-rich lipoproteins 406 Development 132 (2) Research article from the maternal circulation to the embryo for SHH activation Apoptosis and proliferation assays (Willnow et al., 1992; Farese and Herz, 1998). Alternatively, Embryonic day 10.5 embryos were dissected, fixed, paraffin- expression of megalin in the neuroepithelium and its ability to embedded and sectioned as described above. After de-waxing and bind SHH indicates a more direct effect as a co-receptor in rehydration, the sections were incubated with 20 µg/ml proteinase K SHH signaling (McCarthy et al., 2002). in 10 mmol/l Tris/HCl, pH 7.4 for 20 minutes at 37°C. Detection of In the present study, we used mice in which the megalin gene apoptotic cells was performed using the TUNEL reaction kit was ubiquitously inactivated (including yolk sac and (www.Roche.com) following manufacturer’s instructions. For neuroepithelium) or conditional mutants with loss of megalin detection of proliferation, paraffin sections were incubated with rabbit anti-phosphohistone H3 antibody (1:200; Upstate, Lake Placid) only in the neuroepithelium to examine the contribution of the followed by secondary Cy3-conjugated sheep anti-rabbit IgG (Sigma, receptor in these tissues to forebrain formation. Sustained www.sigma.com), and detection by immunofluorescence microscopy. expression of megalin in the yolk sac did not rescue mice from HPE, indicating that a receptor activity in the neuroepithelium BIAcore analysis and cell culture experiments is essential for normal forebrain development. In the Carrier-free preparations of recombinant human BMP4 and neuroepithelium, megalin activity affects dorsal and ventral BMP5 were purchased from Research and Development patterning of the forebrain, and promotes ventral cell fate (www.RnDSystems.com). Recombinant His-tagged RAP was 2+ specification. produced and purified from bacteria by standard Ni affinity chromatography. As a source for WNT1 we used conditioned medium from Rat-2 cells infected with a retroviral Wnt1 expression construct Materials and methods that excrete large amounts of the protein (Rat-2/WNT1) and compared it with medium from cells infected with the empty expression vector Animals (Rat-2/MV7) (cell lines kindly provided by A. M. C. Brown, Cornell The generation of mice with targeted disruption of the megalin gene University, New York) (Giarre et al., 1998). Interaction of megalin has been described (Willnow et al., 1996). The megalin gene defect with BMP4, BMP5 and RAP (0.5-1 µmol/l) or WNT1 (20-fold was analyzed in receptor-deficient and in somite-matched wild-type concentrated medium) was tested by surface plasmon resonance littermates on a hybrid (129SvEmcTer × C57BL/6N) and on an inbred (SPR) as described before (Hilpert et al., 1999). For cell uptake CD1 genetic background. Both lines gave identical results. For studies, BMP4 was iodinated according to the IODOGEN protocol conditional inactivation of the megalin gene in the epiblast, animals (specific activity 3.1×108 cpm/µg). Replicate monolayers of rat homozygous for a loxP-modified allele of the megalin gene choriocarcinoma (BN16) cells were incubated for 2 hours with 1.6 lox/lox (megalin ) (Leheste et al., 2003) were crossed with mice carrying ng/ml of 125I-BMP4 in the presence of buffer, 200 µmol/l chloroquine, a knock-in of the Cre transgene into the mesenchyme homeobox 2 or 100 µg/ml RAP. Degradation of ligand was determined as the total tm1(cre)Sor gene locus (Meox2 ) obtained from Jackson Laboratories amount of 125I-labeled trichloroacetic acid-soluble material released (www.JAX.org) (Tallquist and Soriano, 2000). Embryos from into the culture medium and expressed as picogram ligand per mg of lox/wt tm1(cre)Sor lox/lox breeding of megalin /Meox2 mice with megalin total cell protein (Hilpert et al., 1999). animals were used for phenotypic analysis following genotyping of Development embryo- or yolk sac-derived tissues. Results Histological and immunohistological analysis Megalin deficiency impairs forebrain development Embryos or yolk sac tissues were dissected from pregnant mice at around mid-gestation designated time points, fixed overnight in 4% paraformaldehyde in PBS at 4°C, and embedded in paraffin. Routine
Recommended publications
  • PLATFORM ABSTRACTS Abstract Abstract Numbers Numbers Tuesday, November 6 41
    American Society of Human Genetics 62nd Annual Meeting November 6–10, 2012 San Francisco, California PLATFORM ABSTRACTS Abstract Abstract Numbers Numbers Tuesday, November 6 41. Genes Underlying Neurological Disease Room 134 #196–#204 2. 4:30–6:30pm: Plenary Abstract 42. Cancer Genetics III: Common Presentations Hall D #1–#6 Variants Ballroom 104 #205–#213 43. Genetics of Craniofacial and Wednesday, November 7 Musculoskeletal Disorders Room 124 #214–#222 10:30am–12:45 pm: Concurrent Platform Session A (11–19): 44. Tools for Phenotype Analysis Room 132 #223–#231 11. Genetics of Autism Spectrum 45. Therapy of Genetic Disorders Room 130 #232–#240 Disorders Hall D #7–#15 46. Pharmacogenetics: From Discovery 12. New Methods for Big Data Ballroom 103 #16–#24 to Implementation Room 123 #241–#249 13. Cancer Genetics I: Rare Variants Room 135 #25–#33 14. Quantitation and Measurement of Friday, November 9 Regulatory Oversight by the Cell Room 134 #34–#42 8:00am–10:15am: Concurrent Platform Session D (47–55): 15. New Loci for Obesity, Diabetes, and 47. Structural and Regulatory Genomic Related Traits Ballroom 104 #43–#51 Variation Hall D #250–#258 16. Neuromuscular Disease and 48. Neuropsychiatric Disorders Ballroom 103 #259–#267 Deafness Room 124 #52–#60 49. Common Variants, Rare Variants, 17. Chromosomes and Disease Room 132 #61–#69 and Everything in-Between Room 135 #268–#276 18. Prenatal and Perinatal Genetics Room 130 #70–#78 50. Population Genetics Genome-Wide Room 134 #277–#285 19. Vascular and Congenital Heart 51. Endless Forms Most Beautiful: Disease Room 123 #79–#87 Variant Discovery in Genomic Data Ballroom 104 #286–#294 52.
    [Show full text]
  • Harnessing Low-Density Lipoprotein Receptor Protein 6 (LRP6) Genetic Variation and Wnt Signaling for Innovative Diagnostics in Complex Diseases
    OPEN The Pharmacogenomics Journal (2018) 18, 351–358 www.nature.com/tpj REVIEW Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases Z-M Wang1,2, J-Q Luo1,2, L-Y Xu3, H-H Zhou1,2 and W Zhang1,2 Wnt signaling regulates a broad variety of processes in both embryonic development and various diseases. Recent studies indicated that some genetic variants in Wnt signaling pathway may serve as predictors of diseases. Low-density lipoprotein receptor protein 6 (LRP6) is a Wnt co-receptor with essential functions in the Wnt/β-catenin pathway, and mutations in LRP6 gene are linked to many complex human diseases, including metabolic syndrome, cancer, Alzheimer’s disease and osteoporosis. Therefore, we focus on the role of LRP6 genetic polymorphisms and Wnt signaling in complex diseases, and the mechanisms from mouse models and cell lines. It is also highly anticipated that LRP6 variants will be applied clinically in the future. The brief review provided here could be a useful resource for future research and may contribute to a more accurate diagnosis in complex diseases. The Pharmacogenomics Journal (2018) 18, 351–358; doi:10.1038/tpj.2017.28; published online 11 July 2017 INTRODUCTION signaling pathways and expressed in various target organs.1 LDLR- The Wnt1 gene was identified in 1982. Ensuing studies in related proteins 5/6 (LRP5/6) belong to this large family and Drosophila and Xenopus unveiled a highly conserved Wnt/ function as co-receptors of the Wnt/β-catenin pathway. These β-catenin pathway, namely, canonical Wnt signaling.
    [Show full text]
  • LRP5 Promotes Adipose Progenitor Cell Fitness and Adipocyte Insulin Sensitivity
    bioRxiv preprint doi: https://doi.org/10.1101/2020.03.04.976647; this version posted March 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. LRP5 promotes adipose progenitor cell fitness and adipocyte insulin sensitivity Short title: LRP5 and adipose tissue biology Authors: Nellie Y. Loh1, Senthil K. Vasan1, Manu Verma1, Agata Wesolowska-Andersen2, Matt J. Neville1,3, Clive Osmond4, Celia L. Gregson5, Fredrik Karpe1,3 and Constantinos Christodoulides1. Affiliations: 1 Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7LE, UK 2 Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK 3 NIHR Oxford Biomedical Research Centre, OUH Foundation Trust, Oxford OX3 7LE, UK 4 MRC Lifecourse Epidemiology Unit, Southampton General Hospital, University of Southampton, Tremona Road, Southampton SO17 1BJ, UK 5 Musculoskeletal Research Unit, Translational Health Sciences, University of Bristol, Southmead Hospital, Bristol BS10 5NB, UK Address for correspondence to: Dr Constantinos Christodoulides Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, Oxford OX3 7LE, UK E-mail: [email protected] Phone: +44-1865-857111 Keywords: LRP5, adipose, adipogenesis, fat distribution, WNT, human. Word count: 3964 words, 4 figures, 2 tables 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.03.04.976647; this version posted March 5, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • (LRP5) Is Essential for Normal Cholesterol Metabolism and Glucose-Induced Insulin Secretion
    Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion Takahiro Fujinoa,b, Hiroshi Asabab,c, Man-Jong Kangb,d, Yukio Ikedaa,b,c, Hideyuki Sonea,b, Shinji Takadae,f,g, Dong-Ho Kima, Ryoichi X. Iokaa, Masao Onoh, Hiroko Tomoyorii, Minoru Okuboj, Toshio Murasej, Akihisa Kamatakia, Joji Yamamotoa,c, Kenta Magooria, Sadao Takahashik, Yoshiharu Miyamotoh, Hisashi Oishih, Masato Noseh, Mitsuyo Okazakil, Shinichi Usuil, Katsumi Imaizumii, Masashi Yanagisawac,m, Juro Sakaia,c,n, and Tokuo T. Yamamotoa aGene Research Center and Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University, Sendai 980-8574, Japan; cYanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan Science and Technology Corporation, Tokyo 135-0064, Japan; dDepartment of Animal Science, College of Agriculture, Chonnam National University, Kwangju 500-600, Korea; eGraduate School of Science, Kyoto University, Kyoto 606-8502, Japan; fKondoh Differentiation Signaling Project, Exploratory Research for Advanced Technology, Japan Science and Technology Corporation, Kyoto 606-8305, Japan; gCenter for Integrative Bioscience, Okazaki, Aichi 444-8585, Japan; hDepartments of Pathology and Orthopedics, Ehime University School of Medicine, Ehime 791-0295, Japan; iLaboratory of Nutritional Chemistry, Graduate School of Agriculture, Kyusyu University, Fukuoka 812-8581, Japan; jDepartment of Endocrinology and Metabolism, Toranomon Hospital, Tokyo 105-8470, Japan; kThird Department of Internal Medicine, Fukui Medical University, Fukui 910-1193, Japan; lLaboratory of Chemistry, College of Liberal Arts and Sciences, Tokyo Medical and Dental University, Chiba 282-0827, Japan; and mHoward Hughes Medical Institute, Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75235-9050 Edited by Michael S.
    [Show full text]
  • Associations of Apolipoprotein E and Low‐Density Lipoprotein
    J Periodont Res 2015; 50: 509–518 © 2014 John Wiley & Sons A/S. All rights reserved Published by John Wiley & Sons Ltd JOURNAL OF PERIODONTAL RESEARCH doi:10.1111/jre.12237 H. Gao*, Y. Tian*, H. Meng, J. Hou, Associations of L. Xu, L. Zhang, D. Shi, R. Lu, X. Feng, X. Wang, Z. Chen Department of Periodontology, Peking apolipoprotein E and University School and Hospital of Stomatology, Beijing, China low-density lipoprotein receptor-related protein 5 polymorphisms with dyslipidemia and generalized aggressive periodontitis in a Chinese population Gao H, Tian Y, Meng H, Hou J, Xu L, Zhang L, Shi D, Lu R, Feng X, Wang X, Chen Z. Associations of apolipoprotein E and low-density lipoprotein receptor- related protein 5 polymorphisms with dyslipidemia and generalized aggressive periodontitis in a Chinese population. J Periodont Res 2015; 50: 509–518. © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background and Objective: Dyslipidemia is associated with aggressive periodonti- tis, a condition characterized by the rapid destruction of the periodontium. Apo- lipoprotein E (APOE) and low-density lipoprotein receptor-related protein 5 (LRP5) are involved in immunomodulation and inflammatory activity. We eval- uated the association of LRP5 and APOE polymorphisms with serum lipid con- centrations and generalized aggressive periodontitis within a Chinese population. Material and Methods: Mean serum lipid concentrations were compared across LRP5 and APOE polymorphisms, among cases (n = 185) and controls (n = 138). Multivariable logistic regression was used to evaluate the independent and combined associations of LRP5 and APOE polymorphisms with generalized Huanxin Meng, BDS, MS, PhD, Peking aggressive periodontitis.
    [Show full text]
  • TRAP1 Regulates Wnt/-Catenin Pathway Through LRP5/6 Receptors
    International Journal of Molecular Sciences Article TRAP1 Regulates Wnt/β-Catenin Pathway through LRP5/6 Receptors Expression Modulation 1, 1, 1 1 Giacomo Lettini y, Valentina Condelli y, Michele Pietrafesa , Fabiana Crispo , Pietro Zoppoli 1 , Francesca Maddalena 1, Ilaria Laurenzana 1 , Alessandro Sgambato 1, Franca Esposito 2,* and Matteo Landriscina 1,3,* 1 Laboratory of Pre-Clinical and Translational Research, IRCCS, Referral Cancer Center of Basilicata, 85028 Rionero in Vulture, PZ, Italy; [email protected] (G.L.); [email protected] (V.C.); [email protected] (M.P.); [email protected] (F.C.); [email protected] (P.Z.); [email protected] (F.M.); [email protected] (I.L.); [email protected] (A.S.) 2 Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, 80131 Naples, Italy 3 Medical Oncology Unit, Department of Medical and Surgical Sciences, University of Foggia, 71100 Foggia, Italy * Correspondence: [email protected] (F.E.); [email protected] (M.L.); Tel.: +39-081-7463-145 (F.E.); +39-0881-736-426 (M.L.) These authors have contributed equally to this work. y Received: 4 September 2020; Accepted: 10 October 2020; Published: 13 October 2020 Abstract: Wnt/β-Catenin signaling is involved in embryonic development, regeneration, and cellular differentiation and is responsible for cancer stemness maintenance. The HSP90 molecular chaperone TRAP1 is upregulated in 60–70% of human colorectal carcinomas (CRCs) and favors stem cells maintenance, modulating the Wnt/β-Catenin pathway and preventing β-Catenin phosphorylation/degradation. The role of TRAP1 in the regulation of Wnt/β-Catenin signaling was further investigated in human CRC cell lines, patient-derived spheroids, and CRC specimens.
    [Show full text]
  • Cardiovascular Disease Products
    Cardiovascular Disease Products For more information, visit: www.bosterbio.com Cardiovascular Disease Research Cardiovascular disease is the leading cause of death in developed nations. Boster Bio aims to supply researchers with high-quality antibodies and ELISA kits so they can make new discoveries and help save lives. In this catalogue you will find a comprehensive list of high-affinity Boster antibodies and high sensitivity Boster ELISA kits targeted at proteins associated with cardiovascular disease. Boster: The Fastest Growing About Bosterbio Antibody Company In 2015 Boster is an antibody manufacturer founded in 1993 by histologist Steven Xia. Over the past two decades, Boster and its products have been cited in over 20,000 publications and counting. The firm specializes in developing antibodies and ELISA kits that feature high affinity, Boster Bio received the CitaAb award for high specificity at affordable the greatest increase in number of prices. citations during 2015 than any other antibody manufacturer. Table of Contents Boster Cardiovascular Disease Related Antibodies…………..………..... 2 Boster Cardiovascular Disease Related ELISA Kits……………………..…. 9 1 High Affinity Boster Antibodies Boster supplies only the highest quality antibodies. Our high-affinity polyclonal and monoclonal antibodies are thoroughly validated by Western Blotting, Immunohistochemistry and ELISA. This is our comprehensive catalog of our antibody products related to cardiovascular disease, sorted in alphabetical order by target gene name. Catalog No Product Name
    [Show full text]
  • Supplemental Data
    Supplemental Table 1. Panels (utilized in this study) and the genes included in each of them are summarized below. Nephrotic Syndrome (NS)/Focal ACTN4, ANKFY1, ANLN, APOL1, ARHGAP24, ARHGDIA, CD2AP, CDK20, COL4A3, COL4A4, COL4A5, COL4A6, COQ2, COQ6, COQ8B, CRB2, CUBN, Segmental DGKE, DLC1, EMP2, FAT1, GAPVD1, GON7, INF2, ITGA3, ITGB4, ITSN1, ITSN2, KANK1, KANK2, KANK4, KAT2B, KIRREL1, LAGE3, LAMA5, LAMB2, Glomerulosclerosis LMX1B, MAFB, MAGI2, MYH9, MYO1E, NEU1, NFKB2, NPHS1, NPHS2, NUP107, NUP133, NUP160, NUP205, NUP93, OSGEP, PAX2, PDSS2, PLCE1, (FSGS) Panel PTPRO, SCARB2, SGPL1, SMARCAL1, TBC1D8B, TNS2, TP53RK, TPRKB, TRIM8, TRPC6, TTC21B, WDR4, WDR73, WT1, XPO5, YRDC Alport syndrome COL4A3, COL4A4, COL4A5, COL4A6 Panel Autosomal Dominant Polycystic Kidney DNAJB11, GANAB, HNF1B, PKD1, PKD2 Disease (ADPKD) panel Recessive Polycystic Kidney DZIP1L, PKHD1 Disease (ARPKD) panel Hereditary cystic ANKS6, CEP164, CEP290, CEP83, COL4A1, CRB2, DCDC2, DICER1, DNAJB11, DZIP1L, GANAB, GLIS2, HNF1B, IFT172, INVS, IQCB1, JAG1, LRP5, kidney disease MAPKBP1, MUC1, NEK8, NOTCH2, NPHP1, NPHP3, NPHP4, OFD1, PAX2, PKD1, PKD2, PKHD1, RPGRIP1L, SDCCAG8, SEC61A1, TMEM67, TSC1, panel TSC2, TTC21B, UMOD, VHL, WDR19, ZNF423 Nephrotic NPHS1, NPHS2, WT1, PLCE1, LAMB2 Syndrome Autosomal Dominant and Recessive Polycystic Kidney DNAJB11, DZIP1L, GANAB, HNF1B, PKD1, PKD2, PKHD1 Disease (ADPKD and ARPKD) Panel Distal Renal Tubular Acidosis ATP6V0A4, ATP6V1B1, CA2, SLC4A1 Panel Atypical Hemolytic Uremic syndrome C3, CFB, CFH, CFHR1, CFHR3, CFHR5, CFI, DGKE, MCP, THBD
    [Show full text]
  • Lrp5) on Glucose and Lipid Homeostasis Dinah Foer Yale School of Medicine, [email protected]
    Yale University EliScholar – A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2014 Impact Of Gain-Of-Function Mutations In The Low-Density Lipoprotein Receptor Related Protein 5 (lrp5) On Glucose And Lipid Homeostasis Dinah Foer Yale School of Medicine, [email protected] Follow this and additional works at: http://elischolar.library.yale.edu/ymtdl Recommended Citation Foer, Dinah, "Impact Of Gain-Of-Function Mutations In The Low-Density Lipoprotein Receptor Related Protein 5 (lrp5) On Glucose And Lipid Homeostasis" (2014). Yale Medicine Thesis Digital Library. 1877. http://elischolar.library.yale.edu/ymtdl/1877 This Open Access Thesis is brought to you for free and open access by the School of Medicine at EliScholar – A Digital Platform for Scholarly Publishing at Yale. It has been accepted for inclusion in Yale Medicine Thesis Digital Library by an authorized administrator of EliScholar – A Digital Platform for Scholarly Publishing at Yale. For more information, please contact [email protected]. Impact of gain-of-function mutations in the low-density lipoprotein receptor related protein 5 (LRP5) on glucose and lipid homeostasis A Thesis Submitted to the Yale University School of Medicine in Partial Fulfillment of the Requirements for the Degree of Doctor of Medicine by Dinah Foer 2014 IMPACT OF GAIN-OF-FUNCTION MUTATIONS IN THE LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5 (LRP5) ON GLUCOSE AND LIPID HOMEOSTASIS. Dinah Foer, Meiling Zhu, Christine Simpson, Grace Lee, Rebecca Sullivan, and Karl L. Insogna. Section of Endocrinology, Department of Internal Medicine, Yale University, School of Medicine, New Haven, CT.
    [Show full text]
  • The Roles of Low-Density Lipoprotein Receptor-Related Proteins 5, 6, and 8 in Cancer: a Review
    Hindawi Journal of Oncology Volume 2019, Article ID 4536302, 6 pages https://doi.org/10.1155/2019/4536302 Review Article The Roles of Low-Density Lipoprotein Receptor-Related Proteins 5, 6, and 8 in Cancer: A Review Zulaika Roslan,1,2 Mudiana Muhamad,2 Lakshmi Selvaratnam ,3 and Sharaniza Ab-Rahim 2 Institute of Medical and Molecular Biotechnology, Faculty of Medicine, Universiti Teknologi MARA, Cawangan Selangor, Kampus Sungai Buloh, Sungai Buloh, Selangor, Malaysia Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Universiti Teknologi MARA, Cawangan Selangor, Kampus Sungai Buloh, Sungai Buloh, Selangor, Malaysia Jeffrey Cheah School of Medicine & Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar sunway, Selangor, Malaysia Correspondence should be addressed to Sharaniza Ab-Rahim; sharaniza [email protected] Received 24 July 2018; Revised 5 February 2019; Accepted 26 February 2019; Published 26 March 2019 Academic Editor: Ozkan Kanat Copyright © 2019 Zulaika Roslan et al. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Low-density lipoprotein receptor (LDLR) has been an object of research since the 1970s because of its role in various cell functions. Te LDLR family members include LRP5, LRP6, and LRP8. Even though LRP5, 6, and 8 are in the same family, intriguingly, these three proteins have various roles in physiological events, as well as in regulating diferent mechanisms in various kinds of cancers. LRP5, LRP6, and LRP8 have been shown to play important roles in a broad panel of cancers.
    [Show full text]
  • LRP5 Gene LDL Receptor Related Protein 5
    LRP5 gene LDL receptor related protein 5 Normal Function The LRP5 gene provides instructions for making a protein that is embedded in the outer membrane of many types of cells. It is known as a co-receptor because it works with another receptor protein, frizzled-4 (produced from the FZD4 gene), to transmit chemical signals from outside the cell to the cell's nucleus. Frizzled-4 and the LRP5 protein participate in the Wnt signaling pathway, a series of steps that affect the way cells and tissues develop. Wnt signaling is important for cell division (proliferation), attachment of cells to one another (adhesion), cell movement (migration), and many other cellular activities. The LRP5 protein plays an important role in the development and maintenance of several tissues. During early development, it helps guide the specialization of cells in the retina, which is the light-sensitive tissue at the back of the eye. The LRP5 protein is also involved in establishing a blood supply to the retina and the inner ear. Additionally, this protein helps regulate bone mineral density, which is a measure of the amount of calcium and other minerals in bones. The minerals give the bones strength, making them less likely to break. Health Conditions Related to Genetic Changes Familial exudative vitreoretinopathy More than 15 mutations in the LRP5 gene have been identified in people with the eye disease familial exudative vitreoretinopathy. Some of these mutations change single protein building blocks (amino acids) in the LRP5 protein, while others insert or delete genetic material in the gene. Most of these mutations reduce the amount of functional LRP5 protein that is produced within cells.
    [Show full text]
  • Intracellular Cholesterol Transport Proteins: Roles in Health and Disease Soffientini, Ugo; Graham, Annette
    Intracellular cholesterol transport proteins: roles in health and disease Soffientini, Ugo; Graham, Annette Published in: Clinical Science DOI: 10.1042/CS20160339 Publication date: 2016 Document Version Author accepted manuscript Link to publication in ResearchOnline Citation for published version (Harvard): Soffientini, U & Graham, A 2016, 'Intracellular cholesterol transport proteins: roles in health and disease', Clinical Science, vol. 130, no. 21, pp. 1843-1859. https://doi.org/10.1042/CS20160339 General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Take down policy If you believe that this document breaches copyright please view our takedown policy at https://edshare.gcu.ac.uk/id/eprint/5179 for details of how to contact us. Download date: 26. Sep. 2021 Intracellular Cholesterol Transport Proteins: Roles in Health and Disease Ugo Soffientini§ and Annette Graham* Department of Life Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Cowcaddens Road, Glasgow G4 0BA, United Kingdom *Corresponding Author: Professor Annette Graham, Dept of Life Sciences, School of Health and Life Sciences, Glasgow Caledonian University, 70 Cowcaddens Road, Glasgow G4 0BA, UK T: +44(0) 141 331 3722 F: +44(0) 141 331 3208 E: [email protected] §Present Address: Dr Ugo Soffientini, Jarrett Building, Veterinary Research Facility, University of Glasgow, Garscube, GlasgowG61 1QH, UK. Abstract Effective cholesterol homeostasis is essential in maintaining cellular function, and this is achieved by a network of lipid-responsive nuclear transcription factors, and enzymes, receptors and transporters subject to post-transcriptional and post-translational regulation, while loss of these elegant, tightly regulated homeostatic responses is integral to disease pathologies.
    [Show full text]